Hyperbaric oxygen therapy devices market seen reaching $6.85 billion by 2030

The global hyperbaric oxygen therapy devices market is projected to grow from $5.01 billion in 2026 to $6.85 billion by 2030, driven by diabetes-related wound care demand, wider clinical use and more outpatient and home-based treatment options. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The market outlook points to sustained demand for devices used in wound care, infection control and other adjunctive treatments. - Growth in diabetes and chronic wounds could increase use of hyperbaric oxygen therapy in hospitals, outpatient centers and home-care settings. - The forecast suggests manufacturers and providers are shifting toward portable and monoplace systems as treatment moves beyond traditional hospital use.

What happened: - The Business Research Company released a 2026 market report on hyperbaric oxygen therapy devices. - The report values the market at $5.01 billion in 2026 and projects growth to $6.85 billion by 2030. - The report forecasts a 8.1% compound annual growth rate for 2026 through 2030. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Hyperbaric oxygen therapy devices deliver pure oxygen inside a pressurized chamber. - The higher pressure allows the lungs to absorb more oxygen than under normal atmospheric conditions. - The oxygen is then carried through the bloodstream to tissues and organs. - The report says the therapy supports healing and other therapeutic benefits across a range of medical conditions. - Historical growth was driven by use in decompression sickness, hospital adoption for wound care, rising awareness of oxygen therapies, growth in trauma and emergency services, and broader acceptance of adjunctive hyperbaric applications. - The forecast period is supported by rising chronic wounds and diabetic ulcers, greater demand for non-invasive therapies, growth in outpatient and home healthcare, higher investment in advanced therapeutic technologies, and a wider range of clinical indications. - Anticipated trends include more use in chronic wound care, broader adoption of monoplace and portable devices, greater use in infection control and post-surgical recovery, rising demand for home-based and outpatient solutions, and more standardized treatment and safety protocols. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - Diabetes is a key demand driver because hyperbaric oxygen therapy can accelerate wound healing and tissue repair in patients with diabetic foot ulcers. - In June 2023, the Institute for Health Metrics and Evaluation projected worldwide diabetes cases would rise from 529 million in 2023 to 1.3 billion by 2050. - The same forecast said the global prevalence rate would increase from 6.1% to a much higher level, with North Africa and the Middle East projected to have the highest regional rate at 16.8% by 2050. - The growth outlook also reflects a broader move toward lower-acuity and more convenient care settings. - The shift toward portable and home-based systems suggests the category is moving closer to consumer-friendly treatment models, not just specialty centers.

What's next: - The market is expected to keep expanding as clinical use broadens and more providers add hyperbaric oxygen therapy to wound and recovery care. - Device makers are likely to focus on portable systems, outpatient use and safety standardization. - Regional growth should be strongest in Asia-Pacific as healthcare access and treatment adoption expand.

The bottom line: - Hyperbaric oxygen therapy devices are moving from a niche hospital tool to a broader treatment category, and diabetes-related demand is likely to keep the market growing through 2030.